General Assembly Committee Bill No. 21
January Session, 2017 LCO No. 4432
*04432SB00021INS*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)
General Assembly
Committee Bill No. 21
January Session, 2017
LCO No. 4432
*04432SB00021INS*
Referred to Committee on INSURANCE AND REAL ESTATE
Introduced by:
(INS)
AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (NEW) (Effective January 1, 2018) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state an individual health insurance policy providing coverage of the type specified in subdivision (1), (2), (4), (11), (12) or (16) of section 38a-469 of the general statutes that provides coverage for prescription drugs shall provide coverage for intravenously administered prescription drugs on a basis no less favorable than orally administered prescription drugs.
Sec. 2. (NEW) (Effective January 1, 2018) Each insurance company, hospital service corporation, medical service corporation, health care center, fraternal benefit society or other entity that delivers, issues for delivery, renews, amends or continues in this state a group health insurance policy providing coverage of the type specified in subdivision (1), (2), (4), (11), (12) or (16) of section 38a-469 of the general statutes that provides coverage for prescription drugs shall provide coverage for intravenously administered prescription drugs on a basis no less favorable than orally administered prescription drugs.
This act shall take effect as follows and shall amend the following sections:
Section 1 January 1, 2018 New section
Sec. 2 January 1, 2018 New section
This act shall take effect as follows and shall amend the following sections:
Section 1
January 1, 2018
New section
Sec. 2
January 1, 2018
New section
Statement of Purpose:
To require health insurance policies that provide coverage for prescription drugs to provide coverage for intravenously administered drugs on a basis no less favorable than orally administered drugs.
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]
Co-Sponsors: SEN. LOONEY, 11th Dist.
Co-Sponsors:
SEN. LOONEY, 11th Dist.
S.B. 21